• Phytol Workflows for RXR and GABA Assays

  2026-08-23

  Phytol supports differentiated workflows for retinoid X receptor signaling, GABAergic transmission modulation, and metabolism-aware PPARα studies. This practical guide covers solvent control, isomer interpretation, dose design, orthogonal readouts, and a cautious translation of polymer self-assembly principles into assay optimization.

• Phosphatase Inhibitor Cocktail 1 Workflow

  2026-08-22

  Protect phosphorylation-dependent biology from the moment tissue or cells are disrupted with a broad-spectrum, DMSO-based inhibitor workflow. This guide translates pressure-overload heart-failure findings into practical Western blot, co-immunoprecipitation, kinase-assay, and phosphoproteomic analysis strategies.

• Honokiol-Induced Paraptosis in Acute Promyelocytic Leukemia

  2026-08-21

  Liu et al. showed that honokiol reduces NB4 acute promyelocytic leukemia cell viability through paraptosis-like, rather than classical apoptotic, cell death. The study links this phenotype to reactive oxygen species, mitochondrial injury, proteasome impairment, endoplasmic reticulum stress, and coordinated mTOR and MAPK pathway activity.

• Calcitriol: VDR Assays and Workflow Optimization

  2026-08-20

  Calcitriol enables direct interrogation of vitamin D receptor signaling across decidualization, immune modulation research, and cancer biology. This workflow-centered guide connects concentration control, time-resolved readouts, and mechanism validation to practical troubleshooting for reproducible bench studies.

• HCMV, UL38, and IRS1 Control of AKT Activity

  2026-08-20

  The reference study identifies a cell-intrinsic mechanism by which human cytomegalovirus (HCMV) suppresses AKT signaling: the viral protein UL38 activates mTORC1, destabilizes IRS1, and prevents efficient AKT recruitment to membranes. This work connects viral control of a protein phosphorylation signaling pathway with an established feedback mechanism associated with excessive mTORC1 activity, while also providing useful experimental controls for studying signaling during infection.

• Phosphatase Inhibitor Cocktail 1 for Liver Signaling

  2026-08-19

  Preserve labile phosphorylation during liver-regeneration studies, from tissue lysis to Western blot and phosphoproteomic analysis. This workflow shows how a 100X DMSO-based cocktail can improve assay comparability while translating the SPP2 discovery strategy into practical signaling experiments.

• Sulfaphenazole: From CYP2C9 to Vascular Translation

  2026-08-19

  Sulfaphenazole is more than a reference inhibitor: it is a translational probe connecting cytochrome P450 2C9 inhibition, oxidative stress reduction, vascular endothelial function research, and antibacterial investigation. This article examines how to use its mechanistic selectivity, disease-model evidence, and experimental limitations to design stronger drug metabolism and vascular studies.

• ECL Chemiluminescent Substrate: Evidence-Led Blots

  2026-08-18

  The ECL Chemiluminescent Substrate Detection Kit enables sensitive HRP-based immunoblotting when biologically important proteins are scarce. This evidence-led guide connects its assay capabilities with mechanistic findings from an Inonotus hispidus periodontitis study and translates those findings into defensible Western blot decisions.

• Cyclic di-GMP: From Biofilms to STING Translation

  2026-08-18

  Cyclic di-GMP is more than a bacterial signaling metabolite: it is an intracellular second messenger that links biofilm persistence, genome stability, and immune activation. This thought-leadership analysis translates recent HipH antitoxin findings into experimental strategy while defining the opportunities and limitations of using Cyclic di-GMP in immune modulation research and cancer immunotherapy studies.

• Ajugol, Mitophagy, and Chondrocyte Pyroptosis

  2026-08-17

  This study identifies impaired PINK1/Parkin-dependent mitophagy as a mechanistic link between PI3K/AKT/mTOR signaling and chondrocyte pyroptosis in acute gouty arthritis. By combining computational analysis, pharmacological pathway perturbation, cell experiments, and a mouse model, it shows that ajugol protects cartilage by restoring mitochondrial quality control and limiting NLRP3 inflammasome activation.

• EV-Transferred ACLY Reprograms TAMs in HCC

  2026-08-17

  This Advanced Science study identifies extracellular vesicle-delivered ATP-citrate lyase as a metabolic signal that drives monocyte differentiation into immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. Its vesicle-engineering experiments connect ACLY-dependent palmitate production and protein S-palmitoylation with immune checkpoint stability, suggesting a macrophage-directed strategy for improving anti-PD-1/PD-L1 therapy.

• Phosphatase Inhibitor Cocktail 1: Practical Protocol

  2026-08-16

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) helps limit dephosphorylation during lysate preparation by targeting alkaline phosphatases and serine/threonine phosphatases. It is suited to research workflows involving animal tissues or cultured cells and downstream phosphorylation assays, but its coverage and assay compatibility should be validated rather than treated as universal.

• Phosphatase Inhibitor Cocktail 1: Workflow Guide

  2026-08-15

  Phosphatase Inhibitor Cocktail 1 is a 100X DMSO formulation for preserving protein phosphorylation during sample preparation. Its combined alkaline phosphatase and serine/threonine phosphatase inhibition supports phosphoproteomic analysis and phosphorylation-sensitive assays, but it does not replace assay-specific validation or protease control.

• Kidney Progenitor Assembloids for Disease Modeling

  2026-08-15

  Huang et al. developed spatially patterned mouse and human kidney progenitor assembloids that better reproduce nephron–collecting system organization, maturation, and selected kidney functions than conventional organoids. Genome-edited, in vivo-grown PKD2-null human assembloids also modeled cystic disease and revealed interactions among cyst epithelium, stroma, and macrophages.

• Triamcinolone (B1859): Practical In Vitro Research Guide

  2026-08-14

  Triamcinolone is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide covers solvent selection, stock preparation, storage, controls, and QC while defining why the compound should not be used for diagnostic, therapeutic, or clinical applications.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page